Epidermal growth factor receptor inhibition potentiates chemotherapeutics-mediated sensitization of metastatic breast cancer stem cells.
Trisha KarPrachi DugamSurbhi ShivhareSwathi R ShettySubholakshmi ChoudhuryDebanjan SenBarnali DebSwapan MajumdarSudhan DebnathAmitava DasPublished in: Cancer reports (Hoboken, N.J.) (2024)
Thus, the study suggests that EGFR inhibition-mediated sensitization of the aggressive and metastatic breast CSCs in TNBCs toward chemotherapeutics may reduce the relapse of the disease.